American experts from three different universities talked about the benefits of the Sputnik V coronavirus vaccine, developed by specialists from the Gamaleya Research Center.
Winslow, a specialist in infectious diseases at Stanford University Medical Center, told reporters that the DNA vaccine developed in Russia does not require ultra-low temperatures in order to transport and store it, unlike RNA preparations.
In addition, the expert drew attention to the fact that "Sputnik V" showed efficiency, the level of which can be compared with drugs made in the West.
Daniel Kuritskis, head of the Department of Infectious Diseases at the Harvard University School of Medicine, Massachusetts, also noted that the Russian vaccine can be stored "in an ordinary refrigerator."
“This is a great advantage, since it allows the vaccine to be delivered to those countries where there is much less opportunity to ensure storage at an ultra-low temperature,” the expert noted.
According to the specialist, this feature of the drug suggests that in a number of countries it will be "much easier to use."
In turn, another American infectious disease specialist Roger Kakartur said that the development of Russian specialists is very promising, reports TASS.
“A very interesting technology that provides a level of protection higher than that provided by AstraZenec and Johnson & Johnson vaccines,” said Kakartur.
You can follow all the relevant information about the spread of coronavirus infection in a special section on our website.
